NaNose Medical was founded by private investors together with the Technion Israel Institute of Technology and Hadasah Medical Center.
The Round A investors are a private investor from UAE and a UK fund. We have a strong multidisciplinary leadership with a combined expertise of 50+ years across all aspects of: material science and engineering, molecular biology and DX, computational sciences, data science, and tech transfer and commercialization.
We work closely with clinical advisors to ensure clinically intelligent development of the company’s platform technology in robust clinical validation studies. In addition to the leadership team, NaNose Medical also has a world-class team of academic, clinical, and industry advisors.
